Latest filing published 25 Jun 2021 for Lineage Cell Therapeutics, Inc., €46k.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +9.7%Entry US$3.00 · Close at T+365 US$3.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Neal C. Bradsher: trading record in brief
Neal C. Bradsher is a declared insider at 2 companies (board member); the most frequent names are Questcor Pharmaceuticals Inc and Lineage Cell Therapeutics, Inc. We count 23 filings; the first trade dates from 12 May 2006 and the latest from 25 June 2021.
On the open market, the record shows 11 purchases worth €1.5M and 2 sales worth €1.9M. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 5 option exercises.
Half of the purchases are above €151k and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -30.4%. These figures describe past trades and do not predict future prices.
On 25 June 2021 came the latest disclosure, an option exercise for €46k in Lineage Cell Therapeutics, Inc. The last purchase on record was published on 30 December 2013, which is 4,697 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Neal C. Bradsher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,720 shares@ US$2.20100.0% of flowCommon SharesSEC:0000919574-21-004286:0
- 20,000 shares@ US$2.30Common StockSEC:0000919574-14-003904:0
- 7,500 shares@ US$0.84Common StockSEC:0000919574-14-003489:0
- 69,042 shares@ US$3.53Common StockSEC:0000919574-13-007044:0Canonical exit: 26 Mar 2014 (T+90)
- 00Common StockSEC:0000919574-13-007044:1Canonical exit: 26 Mar 2014 (T+90)
- 56,000 shares@ US$3.53Common StockSEC:0000919574-13-007044:2Canonical exit: 27 Mar 2014 (T+90)
- 00Common StockSEC:0000919574-13-007044:3Canonical exit: 27 Mar 2014 (T+90)
- 175,000 shares@ US$3.49Common StockSEC:0000919574-13-007044:4Canonical exit: 30 Mar 2014 (T+90)
- 00Common StockSEC:0000919574-13-007044:5Canonical exit: 30 Mar 2014 (T+90)
- 15,000 shares@ US$0.90Common StockSEC:0000919574-13-006733:0
- 25,000 shares@ US$0.83Common StockSEC:0000919574-13-006733:1
- 15,000 shares@ US$62.3111Common StockSEC:0000919574-13-006733:2
- 25,000 shares@ US$62.4628Common StockSEC:0000919574-13-006733:3
- 4,183 shares0Common StockSEC:0001181431-13-031381:0
- 2,200,000 shares@ US$1.82COMMON STOCKSEC:0000919574-10-003161:0
- 00COMMON STOCKSEC:0000919574-10-003161:1
- 225,300 shares@ US$0.7698Common StockSEC:0001144204-07-013273:0Canonical exit: 13 Jun 2007 (T+90)
- 200,000 shares@ US$0.75Common StockSEC:0001144204-07-013273:1Canonical exit: 13 Jun 2007 (T+90)
- 200,000 shares@ US$1.45Common StockSEC:0001144204-06-053168:0Canonical exit: 13 Mar 2007 (T+90)
- 100,000 shares@ US$1.67Common StockSEC:0001144204-06-026845:0Canonical exit: 10 Aug 2006 (T+90)
- 135,000 shares@ US$1.51Common StockSEC:0001144204-06-026846:0Canonical exit: 13 Aug 2006 (T+90)
- 135,000 shares@ US$1.51Common StockSEC:0001144204-06-021293:0
- 100,000 shares@ US$1.67Common StockSEC:0001144204-06-021168:0
23 of 23 declarations
